Showing results (1231-1240 of 2,024) with videos related to

Sort By:
Pageof 203
Pharmacogenomics|July 27, 2017
Early health technology assessments in pharmacogenomics: a case example in cardiovascular drugsJoost W Geenen, Ekaterina V Baranova, Folkert W Asselbergs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentMichael L Maitland, Kristen E Kasza, Theodore Karrison, et al.
Respiratory Physiology & Neurobiology|October 21, 2019
Physiological and perceptual responses to exercise according to locus of symptom limitation in COPDLauren Tracey, Hayley Lewthwaite, Sara J Abdallah, et al.
ACS Biomaterials Science & Engineering|July 28, 2020
Microscopic Assessment of Healing and Effectiveness of a Foam-Based Peripheral Occlusion DeviceStaci L Jessen, Molly C Friedemann, Anne-Marie Ginn-Hedman, et al.
The International Journal of Behavioral Nutrition and Physical Activity|October 17, 2020
Development of physical activity policy and implementation strategies for early childhood education and care settings using the Delphi processHayley E Christian, Donna Cross, Michael Rosenberg, et al.
Family Practice|February 5, 2011
Asthma medication use in infancy: determinants related to prescription of drug therapyEllen S Koster, Cornelis K Van der Ent, Cuno S P M Uiterwaal, et al.
The American Journal of Orthopsychiatry|February 17, 2017
Perspectives of veterans with mild traumatic brain injury on community reintegration: Making sense of unplanned separation from serviceAlexander V Libin, Manon Maitland Schladen, Ellen Danford, et al.
The Journal of Pathology|March 1, 1990
The behaviour of human oral squamous cell carcinoma in cell cultureS S Prime, S V Nixon, I J Crane, et al.
Pharmacogenomics|June 11, 2013
Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillationTalitha I Verhoef, William K Redekop, David L Veenstra, et al.
British Journal of Cancer|July 17, 1999
BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital CollaboratorsS Gill, J Broni, S Jefferies, et al.
Pageof 203